Research

Disappearing into thin air: harnessing oxygen drop could eliminate cancers without harming healthy tissue

A major advance towards targeting cancer without harming healthy tissue has been discovered by University of Bristol researchers. The team has found a way to exploit hypoxia (reduced oxygen levels) — a condition which occurs during the development of many common cancers and drives their progression and spread. The findings, which have implications for targeted oncology, are published today [24 August 2018] in the journal EMBO Molecular Medicine.

First in human study to assess knee cartilage repair implant launches at Southmead Hospital

A new first in human study to assess the safety and performance of FibroFix Cartilage P™ (FibroFix™), an innovative implant that repairs knee cartilage, is starting at Southmead Hospital, Bristol. The FFLEX clinical trial has been awarded nearly £1.2million by the National Institute for Health and Care Research (NIHR) and will be led by Orthox, the company behind FibroFix™, and researchers from the University of Bristol.